Lok Sabha Question No. 1515 (UNSTARRED), answered on 2016-05-03
Subject: Removal of Custom Duty Exemption of Life Saving Drugs
Ministry: CHEMICALS AND FERTILIZERS
Asked by: RANGASWAMY DHRUVANARAYANA, BHEEMRAO BASWANTHRAO PATIL, DALPAT SINGH PARASTE

## GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS

## DEPARTMENT OF PHARMACEUTICALS

## LOK SABHA

## UNSTARRED QUESTION No. 1515

## TO BE ANSWERED ON THE 3 rd  May, 2016

## Removal of Custom Duty Exemption of Life Saving Drugs

1515. SHRI R. DHRUVA NARAYANA:

SHRI BHEEMRAO B. PATIL:

SHRI DALPAT SINGH PARASTE:

Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:

- (a) the details of life-saving drugs and bulk drugs used for manufacturing these drugs as well as diagnostic kits removed from customs  duty  exemption  by  the  Central  Board  of  Excise  and Customs (CBEC);
- (b) whether these drugs will now cost 22 per cent more;
- (c) the reasons for removal of these drugs from customs duty exemption and increase in the basic customs duty rate on specified medical devices to 7.5 per cent; and
- (d) the steps being taken by the Government to ensure affordability of these drugs by patients?

## ANSWER

## MINISTER OF STATE IN THE MINISTRY OF CHEMICALS FERTILIZERS (SHRI HANSRAJ GANGARAM AHIR)

## AND

- (a): A statement giving life-saving drugs and bulk drugs used for manufacturing these drugs as well as diagnostic kits removed from customs duty exemption by the Central Board of Excise and Customs (CBEC) is given
- in the attached statement.
- (b) & (d):  In this regard, National Pharmaceutical Pricing Authority (NPPA) has received various representations from the associations/companies requesting  for  increase  in  the  prices  due  to  withdrawal  of  customs  duty.

NPPA  vide  its  letter  dated  28.3.2016  addressed  to  associations/companies advised them to absorb the increase in the cost, if any, as DPCO, 2013 does not have any specific provision in this regard.

- (c): These drugs and medical devices are being indigenously manufactured. It was represented by the domestic industry that continuation of the exemption/ concession of customs/ excise duty is adversely affecting domestic manufacturers. Therefore, exemption/ concessions were withdrawn in line with the Government of India's 'Make in India' Policy.

xxxxxx STATEMENT  REFFERED  TO  IN  PART  (a)  OF  LOK  SABHA  UNSTARRED QUESTION NO. 1515 REGARDING REMOVAL OF CUSTOM DUTY EXEMPTION

## OF LIFE SAVING DRUGS TO BE ANSWERED ON 03.05.2016.

|   Sl. No. | Description of drugs                          |   Sl. No. | Description of drugs             |
|-----------|-----------------------------------------------|-----------|----------------------------------|
|         1 | Allopurinol                                   |        38 | Infliximab                       |
|         2 | Amiodarone                                    |        39 | Interlukin-3                     |
|         3 | Amifostine                                    |        40 | Didanosine                       |
|         4 | Atracurium besylate                           |        41 | Indinavir                        |
|         5 | Carbidopa with Levodopa                       |        42 | Nelfinavir                       |
|         6 | Cefoperazone                                  |        43 | Stavudine                        |
|         7 | Ceftizoxime                                   |        44 | Abacavir sulphate                |
|         8 | Cefpirome                                     |        45 | Lopinavir                        |
|         9 | Dacarbazine                                   |        46 | Tenofovir Disoproxil             |
|        10 | Desmopressin                                  |        47 | Cisplatin                        |
|        11 | Dobutamine                                    |        48 | Dinazole                         |
|        12 | Disodium Pamidronate                          |        49 | Doxorubicin                      |
|        13 | Gemcitabine                                   |        50 | Etoposide                        |
|        14 | Ifosfamide                                    |        51 | Flutamide                        |
|        15 | Interferon alpha- 2b/interferon alpha NL(LNS) |        52 | Flutamide                        |
|        16 | Ketamine                                      |        53 | Ondansetran                      |
|        17 | Levodopa (L-Dopa)                             |        54 | Paclitaxel                       |
|        18 | Lamivudine                                    |        55 | Tamoxifen citrate                |
|        19 | Letrozole                                     |        56 | Exemestane                       |
|        20 | Leuprolide Acetate                            |        57 | Recombinant Interferron beta I-a |
|        21 | Mercaptopurine                                |        58 | Rasburicase                      |
|        22 | Methyl Prednisolone                           |        59 | Posaconazole                     |

|   23. | Mitomycin                                                            | 60.   | Abciximab                                  |
|-------|----------------------------------------------------------------------|-------|--------------------------------------------|
|    24 | Netilmicin                                                           | 61.   | Anti-Rabies Normal Human immunoglobulin    |
|    25 | Naloxone                                                             | 62.   | Anti-D Immunoglobulin                      |
|    26 | Nitroglycerine                                                       | 63.   | Follicle Stimulating Hormone (FSH)         |
|    27 | Micronised Progesterone or Injection                                 | 64.   | Filgrastim / Molgramostim (G- CSF/GM- CSF) |
|    28 | Pilocarpine                                                          | 65.   | Imatinib Mesilate                          |
|    29 | Podophyllotoxin                                                      | 66.   | Irinotecan                                 |
|    30 | Piperacillin                                                         | 67.   | Nalorphine                                 |
|    31 | Pralidoxime                                                          | 68.   | Procarbazine                               |
|    32 | Prazosin                                                             | 69.   | Ritonavir                                  |
|    33 | Streptokinase and Streptodomase preparations                         | 70.   | Rivastigmine                               |
|    34 | Tissue Plaaminogen Activator                                         | 71.   | Rituximab                                  |
|    35 | Recombinant human Erythropoietin                                     | 72.   | Saquinavir                                 |
|    36 | Lopinavir plus Ritonavir (co-formulation of Lopinavir and Ritonavir) | 73.   | Trastuzumab                                |
|    37 | Capecitabine                                                         |       |                                            |

xxxxxx